Revidea is a biotechnology focused investment fund operating in both the public and private markets.
At Revidea we are committed to finding and assisting extraordinary companies working on technological breakthroughs and medical advances that will change the world. We seek to partner with truly innovative companies looking to make a real impact on peoples lives.
We are not interested in the incremental — we seek the revolutionary.
Strategy
Revidea is built on an unbiased and intensive proprietary research process designed to keep us ahead of the curve. Each day we strive to build on our experience and deepen our understanding within our select areas of focus.
The fund aims to invest in a highly concentrated fashion with a long term time horizon. We believe operating without bias while being laser focused on a few select areas will bring outstanding results.
Each year Revidea will look to donate a significant portion of profits to world class institutions such as the Lymphoma & Leukemia Society, Memorial Sloan Kettering Cancer Center and Columbia University.
Team
Thomas Turalski leads the Revidea investment team. He has over seventeen years of experience in the biotechnology arena ranging from public and private investing and exposure to the corporate, operational and regulatory side of company development.
Most recently Thomas spent eleven years at Perceptive Advisors, a top ranked healthcare investment fund. At Perceptive Thomas led investments in Myogen, Morphosys and Pharmacyclics among many others. He was also responsible for the firm’s investment in Acerta Pharma where he was a member of the founding team as well as the board of directors.
He has a BA from Columbia University where he was a member of the men’s soccer team.
Revolutionaries need apply.
Contact Us- phone 203 / 518 / 8000
- email info@revideaventures.com